Delineation of the Prostate Bed: The “Invisible Target” Is Still an Issue?

For pathological high-risk prostate cancer, adjuvant irradiation has shown a survival benefit. Phase III studies have highlighted that half men would face biochemical relapse and would be candidate for radiotherapy at adjuvant or salvage times. Despite at least four published international contourin...

Descripción completa

Detalles Bibliográficos
Autores principales: Latorzeff, Igor, Sargos, Paul, Loos, Geneviève, Supiot, Stéphane, Guerif, Stéphane, Carrie, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5449739/
https://www.ncbi.nlm.nih.gov/pubmed/28620579
http://dx.doi.org/10.3389/fonc.2017.00108

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5449739/
https://www.ncbi.nlm.nih.gov/pubmed/28620579
http://dx.doi.org/10.3389/fonc.2017.00108

Ejemplares similares